Uptake or Heartbreak with Biosimilars? Progress and Perspectives
Webinar Recorded on Feb. 24, 2021
To download a copy of the webinar slides, please complete this request form.
While biosimilars have made great strides since the first US launch in 2015, have they achieved the level of impact first anticipated? Some argue there is still room for growth, including questions around the role reimbursement and formulary placement play in their level of adoption. This webinar will look at how payer decision-making is affecting overall adoption of biosimilars, cost reduction and ultimately impact on patients.
Join this session to hear our group of experts discuss:
- Current biosimilars reimbursement trends
- Payer perception and treatment of biosimilars in formulary decision making
- Key considerations for manufacturers to support effective reimbursement and formulary placement
- What’s on the horizon in the biosimilars space
Moderator:
- Jocelyn Ulrich, MPH
Deputy Vice President, Policy, Research and Membership
PhRMA
Speakers:
- April M. Kunze
Sr. Director, Clinical Formulary Development & Trend Management Strategy
Prime Therapeutics - Laurie Fazio
Head of Market Access
FormularyDecisions - Amanda O’Hora
Senior Director, Reimbursement Policy Insights
Xcenda
Featured News & Resources
See Full CalendarNews & Resources by Topic
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.